Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EBT (2020 - 2025)

Trulieve Cannabis has reported EBT over the past 6 years, most recently at $2.9 million for Q4 2025.

  • Quarterly results put EBT at $2.9 million for Q4 2025, up 122.79% from a year ago — trailing twelve months through Dec 2025 was $91.5 million (up 114.15% YoY), and the annual figure for FY2025 was $91.5 million, up 114.15%.
  • EBT for Q4 2025 was $2.9 million at Trulieve Cannabis, down from $29.3 million in the prior quarter.
  • Over the last five years, EBT for TCNNF hit a ceiling of $70.0 million in Q2 2021 and a floor of -$308.2 million in Q2 2023.
  • Median EBT over the past 5 years was $13.4 million (2022), compared with a mean of $174350.0.
  • Biggest five-year swings in EBT: tumbled 1265.17% in 2023 and later skyrocketed 2644.5% in 2024.
  • Trulieve Cannabis' EBT stood at -$18.6 million in 2021, then grew by 5.22% to -$17.6 million in 2022, then skyrocketed by 150.09% to $8.8 million in 2023, then crashed by 246.25% to -$12.9 million in 2024, then soared by 122.79% to $2.9 million in 2025.
  • The last three reported values for EBT were $2.9 million (Q4 2025), $29.3 million (Q3 2025), and $38.9 million (Q2 2025) per Business Quant data.